Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-016162

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Roger D Tung
Officer — Chief Executive Officer · Director
Period of report
Feb 17, 2015
Accepted (ET)
Feb 19, 2015 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 17, 2015M28,495$1.13A490,017D
Common StockF1holding———13,274IBy Tung Family Investment Trust
Common StockF2holding———134,761IBy Roger D. Tung 2011 GRAT
Common StockF3holding———12,389IBy RD Tung Irrevocable Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F4$1.13Feb 17, 2015M28,495D—Dec 11, 2017Common Stock28,4950D

Explanation of responses